PHARMACEUTICAL STABILITY AND STORAGE SERVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• On January 24, 2024, Alcami Corporation, a leading contract development and manufacturing organization (CDMO), announced the opening of a new 65,000 ft² plant in Garner, North Carolina, near the Research Triangle Park biotech and pharma hub. The new facility in central North Carolina accepts customer pallets for ambient/controlled room temperature storage, expanding the company's network of GMP storage facilities across North America.
• In March 2022, Alcami, a leading contract development and manufacturing organization (CDMO), announced plans to increase its biostorage footprint at Masy BioServices. A new 160,000 square-foot facility, purpose-built for cGMP pallet storage space at 15°C to 30°C, will be added to the company's current New England campus.
• In October 2022, Cambrex, a contract development manufacturing organisation, announced the expansion of its stability storage company, Q1 Scientific, which provides environmentally controlled stability storage services to the pharmaceutical, medical device, and life sciences industries. Q1 Scientific will establish a new 20,000-square-foot cGMP facility in Belgium and expand its existing Waterford, Ireland facility by 10,000 square feet.
• In July 2021, LGM Pharma, an active pharmaceutical ingredient companies, announced the launch of its new Analytical Services offering, which offers analytical testing and stability services to pharmaceutical inventors and manufacturers, including compounding pharmacies. The company, which currently provides analytical services as part of its integrated contract development and manufacturing (CDMO) activities, is now offering its analytical services knowledge and facilities as a separate contract service to pharmaceutical industry clients.